Antioxidant supplements and cardiovascular disease in men

JAMA

Volumn 301, Issue 13, 2009, Pages 1335-

  Violi, Francesco ^a   Cangemi, Roberto ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTIOXIDANT; VITAMIN;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE COURSE; DRUG INDICATION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION; DIET SUPPLEMENTATION; DRUG INTERACTION; MALE; NOTE; BIOAVAILABILITY;

ANTIOXIDANTS; ASCORBIC ACID; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; VITAMIN E; VITAMINS; BIOLOGICAL AVAILABILITY;

EID: 63849201334     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.314     Document Type: Letter

References (5)

1. Sesso HD, Buring JE, Christen WG, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2008;300(18):2123-2133.
2. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361(9374):2017-2023.
3. Cangemi R, Loffredo L, Carnevale R, et al. Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin E. Eur Heart J. 2008;29(1):54-62.
4. Violi F, Cangemi R. Statin treatment as a confounding factor in human trials with vitamin E. J Nut. 2008;138(6):1179-1181.
5. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):23-33.